GPT Healthcare Ltd

NSE : GPTHEALTH07 Feb 2025

Healthcare

₹

-2.58 (-1.53%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in GPT Healthcare Ltd

GPT Healthcare Ltd

Healthcare

NSE : GPTHEALTH07 Feb 2025

₹

-2.58 (-1.53%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
14-Nov-2024	D	Please find the intimation of Record date for the First interim Dividend for the FY 2024-25. Please find the outcome of the Board Meeting dated November 14, 2024. Declaration of First Interim Dividend @ 10 % (Re. 1.00 per equity share) for the Financial Year 2024-25.	28-Nov-2024
21-May-2024	D	The board of Directors of the Company have recommended Final Dividend of 15 % i.e. Rs 1.50 per equity share on the face value of Rs. 10 each for the financial year ended March 31, 2024, subject to the approval of the shareholders in the ensuing 35th Annual General Meeting of the Company.	18-Jul-2024
19-Mar-2024	D	Please find enclosed herewith the outcome of the Board Meeting dated March 19, 2024. Declaration of Second Interim Dividend @10% (1 per equity share) for the Financial Year 2023-24. The Board has fixed Monday, April 01, 2024 as the 'Record Date' to ascertain the names of the shareholders / beneficial owners of the Company to whom the aforesaid interim dividend shall be payable. Please find enclosed herewith the revised date of record date for the second interim dividend for the FY 2023-24. (As Per BSE Announcement dated on 19.03.2024)	02-Apr-2024
14-Nov-2024	BC	Please find the intimation of Record date for the First interim Dividend for the FY 2024-25. Please find the outcome of the Board Meeting dated November 14, 2024. Declaration of First Interi	31-Mar-2025
22-Jan-2025	BC	GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone) alo	11-Feb-2025
14-Nov-2024	BC	Please find the intimation of Record date for the First interim Dividend for the FY 2024-25.	28-Nov-2024
14-Nov-2024	BC	10% 1st Interim Dividend	28-Nov-2024
04-Nov-2024	BC	GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. the Unaudited Financial Results (Standalo	14-Nov-2024

No Rights has been declared by GPTHEALTH

Book Closure

Record Date	Split Date	Purpose
31-Mar-2025	-	Please find the intimation of Record date for the First interim Dividend for the FY 2024-25. Please find the outcome of the Board Meeting dated November 14, 2024. Declaration of First Interi
11-Feb-2025	-	GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone) alo
28-Nov-2024	-	Please find the intimation of Record date for the First interim Dividend for the FY 2024-25.
28-Nov-2024	-	10% 1st Interim Dividend
14-Nov-2024	-	GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. the Unaudited Financial Results (Standalo

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
GPT Healthcare Ltd ₹165.66(-2.58/-1.53%)	165.66	-2.58	1,359.32	-17.46	27.70	5.88
Poly Medicure Ltd ₹2,418.50(-15.40/-0.63%)	2,418.50	-15.40	24,505.62	50.05	77.74	9.52
Fortis Healthcare Ltd ₹650.15(-0.95/-0.15%)	650.15	-0.95	49,083.60	43.71	258.84	5.40
Indegene Ltd ₹629.15(+5.20/0.83%)	629.15	+5.20	15,056.21	10.20	85.49	8.49
Syngene International Ltd ₹744.85(-1.50/-0.20%)	744.85	-1.50	29,982.97	-0.99	65.31	6.95
Shalby Ltd ₹216.27(-6.79/-3.04%)	216.27	-6.79	2,335.93	-30.56	25.70	2.14

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	6.60	8.27	4.78	0.35	1.28
Net Cash from Operating Activities	68.80	66.36	65.99	42.99	41.46
Net Cash Used In Investing Activities	-25.21	5.15	-5.34	-16.45	-54.31
Net Cash Used In Financing Activities	-48.50	-73.18	-57.16	-22.11	11.91
Net Inc./Dec In Cash And Cash Equivalents	-4.91	-1.67	3.49	4.43	-0.93
Cash And Cash Equivalents At End Of The Year	1.69	6.60	8.27	4.78	0.35

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

65.57%

FII Shareholding

4.72%

DII Shareholding

11.30%

Public Shareholding

18.41%

**Promoter pledged shareholding 65.57%

About GPT Healthcare Ltd

GPT Healthcare Ltd is in the Healthcare sector, having a market capitalization of Rs. 1359.24 crores. It has reported a sales of Rs. 99.43 crores and a net profit of Rs. 12.82 crores for the quarter ended December 2018. The company management includes , D P Tantia,Om Tantia,Aruna Tantia,Anurag Tantia,Ghanshyam Goyal,Deepak Pramanik,Kashi Prasad Khandelwal,Amrendra Verma,Hari Modi,Tapti Sen,Ankur Sharma (GPT Healthcare Ltd) among others.

Chairman

Registered office

GPT Centre JC-25 Sector-III,Salt Lake,Kolkata,West Bengal,700106

FAX :

Background

Incorporation Year1989

Face Value₹10

Market Lot1